Icon

TECHNIVIE (nda207931)- (12.5MG;75MG;50MG)

OMBITASVIR; PARITAPREVIR; RITONAVIR ABBVIE
12.5MG;75MG;50MG
No No
2032-Apr-13 2019-Dec-19
None 2018-Jul-24
None No
TECHNIVIE is a fixed-dose combination of ombitasvir, a hepatitis C virus NS5A inhibitor, paritaprevir, a hepatitis C virus NS3/4A protease inhibitor, and ritonavir, a CYP3A inhibitor and is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis.
0 0 0
Total Other Developers None
Drugs with Suitability No
12.5MG;75MG;50MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.